全球器官保存市場規模（依保存技術、器官類型、最終用戶、地區、範圍和預測）

器官保存市場規模及預測

2024 年器官保存市場規模價值為 2.5934 億美元，預計到 2032 年將達到 4.1424 億美元，2026 年至 2032 年的複合年成長率為 6.65%。

器官保存是指確保用於移植或研究的器官的活力和功能性的策略和方法。器官保存至關重要，因為器官從捐贈者體內取出後必須保持良好狀態，以避免器官劣化，並在移植到接受者體內時保持正常功能。

器官保存是移植醫學中的重要技術，旨在保持器官在移植過程中的活力和功能。器官保存的主要應用包括肝臟、腎臟、心臟、肺部和胰臟移植。為了提高器官在運輸和儲存過程中的存活率，器官保存策略包括靜態低溫保存、低溫灌注和常溫灌注。

隨著技術突破和研究進展，器官保存的未來前景一片光明。諸如體內保存以及使用合成培養基在高溫下保存器官等新技術正在被研究，以延長保存時間並提高器官品質。

全球器官保存市場動態

關鍵市場促進因素

器官移植率不斷提升：隨著糖尿病、高血壓和肝病等慢性疾病導致器官衰竭的發生率不斷上升，器官移植的需求也將隨之成長。隨著尋求器官移植的人數不斷增加，對高效能器官保存策略的需求也將隨之成長。提高移植成功率將促使醫院和醫療機構投資更先進的器官保存技術，進而推動市場擴張。

器官保存技術的進步：低溫灌注和強化冷凍保存等器官保存技術的創新，提高了器官的存活率，並延長了儲存和運輸過程中的壽命。這些進展提高了移植的成功率，並使器官保存技術對醫護人員更具吸引力。

政府計劃和意識提升計畫：世界各國政府和組織越來越認知到器官捐贈和器官保存的價值。旨在提高器官捐贈意識、提高捐贈率並引入改進的器官保存方法的計劃正日益增多。這些計畫不僅鼓勵更多人註冊成為器官捐贈者，也促進了現代器官保存技術在醫療保健領域的應用。

主要挑戰

器官供應有限：器官保存面臨的最大問題之一是適當的移植器官短缺。儘管器官保存方法不斷進步，但器官供需之間仍存在巨大缺口。捐贈者資質、公眾認知以及器官捐贈的文化觀念等因素加劇了這個問題。

技術限制：冷藏和低溫灌注等器官保存技術雖然取得了進展，但仍有其限制。這些技術只能在有限的時間內延長器官存活時間，並增加了缺血和細胞損傷的風險。

監管與合規問題：器官保存產業受到嚴格監管，對所使用的技術和產品都有嚴格的標準。對於企業而言，遵守這些法規可能既困難又耗時，從而減緩新技術的採用並增加營運成本。遵守這些標準對於市場參與企業至關重要，但對於中小型企業而言，遵守這些標準可能並非易事。

主要趨勢：

技術進步：低溫機械灌注和常溫局部灌注等新的器官保存技術正在提高移植器官的存活率。這些創新技術不僅延長了器官的保存時間，也改善了移植後器官的功能。

器官移植需求日益成長：隨著糖尿病和肝硬化等慢性疾病的日益普遍，器官移植的需求也日益成長。隨著等待器官移植的人數不斷增加，有效的器官保存措施變得越來越重要。這一趨勢推動了對器官移植研發的投入，旨在改善器官保存技術，以滿足日益成長的需求。

監管支持和舉措：各國政府和衛生組織正在推出鼓勵器官捐贈和移植的計畫。監管機構也在製定規則，鼓勵使用先進的器官保存技術。此類支持有助於改善器官保存方法，提高器官的可獲得性，進而改善器官移植的整體情況。

目錄

第1章 引言

• 市場定義
• 市場區隔
• 調查方法

第2章執行摘要

• 主要發現
• 市場概覽
• 市場亮點

第3章市場概述

• 市場規模和成長潛力
• 市場趨勢
• 市場促進因素
• 市場限制
• 市場機會
• 波特五力分析

第4章 器官保存市場（依保存技術）

• 概述
• 靜態冷藏（SCS）
• 低溫機灌注（HMP）
• 常溫機械灌注（NMP）

第5章 器官保存市場（依器官類型）

• 概述
• 腎
• 肝
• 心
• 肺
• 胰臟
• 其他

第6章 器官保存市場（依最終使用者）

• 概述
• 醫院及移植中心
• 器官獲取組織（OPO）
• 研究機構和研究中心

第7章區域分析

• 概述
• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第8章市場動態

• 市場促進因素
• 市場限制
• 市場機會
• COVID-19 市場影響

第9章 競爭態勢

• 主要企業
• 市場佔有率分析

第10章 公司簡介

• Overview
• XVIVO Perfusion
• TransMedics
• OrganOx Limited
• Franz Kohler Chemie GmbH
• Essential Pharmaceuticals LLC
• Preservation Solutions, Inc.
• BioLifeSolutions Inc.
• Bridge to Life Ltd.
• 21st Century Medicine
• Paragonix Technologies Inc

第11章 市場展望與機會

• 新興技術
• 未來市場趨勢
• 投資機會

第12章 附錄

• 簡稱列表
• 來源和參考文獻

Organ Preservation Market Size and Forecast

Organ Preservation Market size was valued at USD 259.34 Million in 2024 and is projected to reach USD 414.24 Million by 2032, growing at a CAGR of 6.65% from 2026 to 2032.

Organ preservation refers to the strategies and methods used to ensure the viability and functionality of organs for transplantation or study. This method is critical because organs must be kept in good condition after being removed from a donor to avoid deterioration and ensure they function properly when transplanted into a recipient.

It is a vital technique in transplantation medicine that aims to keep organs viable and functional for transplantation. The principal applications of organ preservation include liver, kidney, heart, lung, and pancreatic transplants. Various preservation strategies, including static cold storage, hypothermic machine perfusion, and normothermic machine perfusion are used to increase organ viability during transport and storage.

The future of organ preservation seems promising, thanks to technical breakthroughs and greater study. Emerging techniques such as biopreservation and the use of synthetic media to keep organs viable at higher temperatures are being investigated to prolong preservation times and improve organ quality.

Global Organ Preservation Market Dynamics

The key market dynamics that are shaping the global organ preservation market include:

Key Market Drivers:

Increasing Organ Transplantation Rates: As the frequency of organ failure from chronic diseases such as diabetes, hypertension, and liver disease rises so does the demand for organ transplants. As more people seek organ transplants, the necessity for efficient organ preservation strategies grows. Improved transplant success rates motivate hospitals and healthcare facilities to invest in enhanced preservation technologies which drives market expansion.

Advances in Preservation Technologies: Innovations in organ preservation technologies such as hypothermic machine perfusion and enhanced cryopreservation procedures have increased organ viability and longevity during storage and transport. These developments increase the likelihood of a successful transplant making preservation technology more enticing to healthcare professionals.

Government Initiatives and Awareness Programs: Governments and organizations around the world are increasingly realizing the value of organ donation and preservation. Initiatives to raise awareness about organ donation, increase donation rates, and introduce improved preservation procedures are becoming more common. Such programs not only encourage more people to register as organ donors but they also promote the use of modern preservation technology in healthcare settings.

Key Challenges:

Limited Availability of Organs: One of the most significant issues in organ preservation is the lack of suitable organs for transplantation. Despite advances in preservation procedures, there is still a considerable gap between organ demand and supply. Factors such as organ donor eligibility, public knowledge, and cultural views toward organ donation all worsen the problem.

Technological Limitations: Although organ preservation technologies like as cold storage and hypothermic machine perfusion have advanced, they are still limited. These techniques can only extend organ viability for a limited time increasing the risk of ischemia and cell damage.

Regulatory and Compliance Issues: The organ preservation industry is highly regulated with strict criteria governing the techniques and goods used. Navigating these restrictions can be difficult and time-consuming for businesses, potentially delaying the adoption of new technologies and increasing operational costs. Compliance with these standards is critical for market participants but it can be difficult, particularly for smaller companies.

Key Trends:

Technological Advancements: New organ preservation procedures such as hypothermic machine perfusion and normothermic regional perfusion are increasing the survivability of organs for transplantation. These innovative procedures not only increase the preservation period but also improve organ function after transplantation.

Increased Demand for Organ Transplants: As chronic diseases like diabetes and liver cirrhosis become more common, there is a greater demand for organ transplants. As waiting lists for organ transplants rise, effective preservation measures become increasingly important. This trend is pushing investment in R&D with a focus on improving organ preservation technologies to satisfy increasing demand.

Regulatory Support and Initiatives: Governments and health organizations are launching programs to encourage organ donation and transplantation. Regulators are also developing rules to encourage the use of advanced preservation technology. Such support improves the entire picture of organ transplantation by enabling better preservation methods and increasing organ availability.

Global Organ Preservation Market Regional Analysis

Here is a more detailed regional analysis of the global organ preservation market:

North America:

North America dominates the organ preservation market owing to its advanced healthcare infrastructure and high organ transplant rates. This dominance is reinforced by significant government financing, extensive research projects, and an established network of organ procurement groups. The United States leads in organ transplantation in North America, with the United Network for Organ Sharing (UNOS) reporting 41,354 organ transplants in 2021, up 5.9% from 2020.

According to data from the Organ Procurement and Transplantation Network (OPTN), there were 104,888 candidates on the national transplant waiting list in February 2023, highlighting the crucial need for organ preservation technology to maximize the viability of available organs. The U.S. Department of Health and Human Services reports that 17 people die each day waiting for an organ transplant emphasizing the urgency for advanced preservation methods to increase the pool of viable organs.

According to the Canadian Institute for Health Information, 2,782 organ transplants were performed in 2021, representing a 13% increase from 2020. The Canadian government has invested CAD 36.5 million over five years to improve the organ donation and transplantation system, which includes funding for preservation technologies.

Asia Pacific:

The rapidly increasing rate of organ transplants is the fastest-growing driver of the Asia Pacific organ preservation market. This acceleration is mostly owing to improved healthcare infrastructure, increased public awareness of organ donation, and government attempts to promote transplantation programs. In China, the number of organ transplants has significantly increased. The Commission also projected that the number of registered organ donors in China will reach 2.54 million by the end of 2020, up from 1,087 in 2010.

According to the National Organ and Tissue Transplant Organisation (NOTTO), the rate of organ donation in India has increased from 0.08 per million people in 2012 to 0.65 per million by 2021. Australia and New Zealand have also helped to drive regional growth, with the Australia and New Zealand Organ Donation Registry reporting 1,444 organ transplants in 2020, despite the pandemic's hurdles. These figures highlight the growing demand for effective organ preservation options in the Asia Pacific region. Furthermore, the World Health Organization estimates that the prevalence of chronic diseases, a primary driver of organ transplantation, will increase by 57% in the Asia Pacific region.

Global Organ Preservation Market: Segmentation Analysis

The Global Organ Preservation Market is segmented based on Preservation Technique, Organ Type, End-User, and Geography.

Organ Preservation Market, By Preservation Technique

• Static Cold Storage (SCS)
• Hypothermic Machine Perfusion (HMP
• Normothermic Machine Perfusion (NMP)

Based on the Preservation Technique, the Global Organ Preservation Market is bifurcated into Static Cold Storage (SCS), Hypothermic Machine Perfusion (HMP, Normothermic Machine Perfusion (NMP). In the global organ preservation market, static cold storage (SCS) remains the dominant technique due to its widespread acceptance and established protocols for preserving organs before transplantation. SCS is cost-effective, simple to implement, and requires minimal equipment making it accessible for many hospitals and transplant centers. It is particularly effective for short-term preservation of organs such as kidneys and livers.

Organ Preservation Market, By Organ Type

• Kidneys
• Liver
• Heart
• Lungs
• Pancreas
• Others

Based on the Organ Type, the Global Organ Preservation Market is bifurcated into Kidneys, Liver, and Heart, Lungs, Pancreas, Others. In the global organ preservation market, the kidneys segment is the dominant category. This dominance is primarily due to the high prevalence of kidney diseases including chronic kidney disease and end-stage renal failure which necessitate organ transplants. The increasing number of dialysis patients seeking transplants amplifies the demand for kidney preservation solutions. Additionally, advancements in preservation technologies such as hypothermic machine perfusion, enhance the viability and longevity of kidney transplants, further propelling this segment's growth.

Organ Preservation Market, By End-User

• Hospitals and Transplant Centres
• Organ Procurement Organizations
• Research Institutes and Laboratories

Based on the End-User, the Global Organ Preservation Market is bifurcated into Hospitals and Transplant Centres, Organ Procurement Organizations, Research Institutes and Laboratories. In the global organ preservation market, hospitals and transplant centers are the dominant end-users. This dominance stems from their central role in the organ transplantation process where the preservation of organs is critical for successful outcomes. Hospitals and transplant centers are equipped with specialized facilities and expertise to ensure optimal preservation conditions facilitating the timely transplantation of harvested organs. Moreover, the increasing number of organ transplant procedures due to rising organ failure rates and advancements in transplantation technologies further drive the demand for preservation solutions in these settings.

Organ Preservation Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Organ Preservation Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is the dominant region in the global organ preservation market. This leadership is primarily attributed to advanced healthcare infrastructure, high rates of organ transplantation, and significant investments in research and development. The presence of key players and cutting-edge technologies further enhances the region's market position. Additionally, stringent regulations and standards governing organ preservation practices in North America drive innovation and ensure high-quality preservation solutions.

Key Players

The "Global Organ Preservation Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are XVIVO Perfusion, TransMedics, OrganOx Limited, Franz Kohler Chemie GmbH, Essential Pharmaceuticals LLC, Preservation Solutions, Inc., BioLifeSolutions, Inc., Bridge to Life Ltd., 21st Century Medicine, and Paragonix Technologies, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Organ Preservation Market Key Developments

• In August 2022, Paragonix Technologies, Inc. achieved a critical milestone by preserving over 2,000 donor organs while delivering Advanced Organ Preservation (AOPT) technology and a statewide clinical support network. Each of these systems incorporates novel preservation methods, considerably improving traditional ice and cooler processes.
• In January 2023, transplant surgeons at MedStar Georgetown University Hospital in the Washington Metropolitan area of the United States successfully utilized a new FDA-approved technology, the OrganOx metra, which simulates connecting a liver to its recipient, allowing the donated liver to be preserved for up to 12 hours before being transplanted into the recipient.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Organ Preservation Market, By Preservation Technique

• Overview
• Static Cold Storage (SCS)
• Hypothermic Machine Perfusion (HMP)
• Normothermic Machine Perfusion (NMP)

5. Organ Preservation Market, By Organ Type

• Overview
• Kidneys
• Liver
• Heart
• Lungs
• Pancreas
• Others

6. Organ Preservation Market, By End-User

• Overview
• Hospitals and Transplant Centers
• Organ Procurement Organizations (OPOs)
• Research Institutes and Laboratories

7. Regional Analysis

• Overview
• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Overview
• XVIVO Perfusion
• TransMedics
• OrganOx Limited
• Franz Kohler Chemie GmbH
• Essential Pharmaceuticals LLC
• Preservation Solutions, Inc.
• BioLifeSolutions Inc.
• Bridge to Life Ltd.
• 21st Century Medicine
• Paragonix Technologies Inc

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References